Andrew Lo insider trades
Open-market stock purchases and sales by Andrew Lo, Director at BridgeBio Pharma, Inc, from SEC Form 4 filings since Oct 16, 2017.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -68%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Nov 18, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $1.6M |
| Nov 18, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $2M |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $2.5M |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $255K |
Companies traded
- BBIO BridgeBio Pharma, Inc: 2 buys, 5 sales, last Jun 22, 2026
- ABCL AbCellera Biologics Inc: 1 buy, last Jun 12, 2025
- ROIV Roivant Sciences Ltd: other filings, last Sep 15, 2022
- UROV Urovant Sciences Ltd: 27 buys, last Jun 19, 2019
- MYOV Myovant Sciences Ltd: 2 buys, last Jun 4, 2019
- AXON Axovant Sciences Ltd: 3 buys, last Mar 18, 2019
- ABUS Arbutus Biopharma Corp: 2 buys, last Jan 12, 2018